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Background:Pathophysiologic processes supporting abnormal emotion regulation inmajor
depressive disorder (MDD) are poorly understood. We previously found abnormal inverse
left-sided ventromedial prefrontal cortical–amygdala effective connectivity to happy faces
in females with MDD. We aimed to replicate and expand this previous ﬁnding in an inde-
pendent participant sample, using a more inclusive neural model, and a novel emotion
processing paradigm. Methods: Nineteen individuals with MDD in depressed episode
(12 females), and 19 healthy individuals, age, and gender matched, performed an implicit
emotion processing and automatic attentional control paradigm to examine abnormalities
in prefrontal cortical–amygdala neural circuitry during happy, angry, fearful, and sad face
processing measured with functional magnetic resonance imaging in a 3-T scanner. Effec-
tive connectivity was estimated with dynamic causal modeling in a trinodal neural model
including two anatomically deﬁned prefrontal cortical regions, ventromedial prefrontal cor-
tex, and subgenual cingulate cortex (sgACC), and the amygdala. Results:We replicated our
previous ﬁnding of abnormal inverse left-sided top-down ventromedial prefrontal cortical–
amygdala connectivity to happy faces in females with MDD (p = 0.04), and also showed
a similar pattern of abnormal inverse left-sided sgACC–amygdala connectivity to these
stimuli (p = 0.03).These ﬁndings were paralleled by abnormally reduced positive left-sided
ventromedial prefrontal cortical–sgACC connectivity to happy faces in females with MDD
(p = 0.008), and abnormally increased positive left-sided sgACC–amygdala connectivity to
fearful faces in females, and all individuals, with MDD (p = 0.008; p = 0.003). Conclu-
sion: Different patterns of abnormal prefrontal cortical–amygdala connectivity to happy
and fearful stimuli might represent neural mechanisms for the excessive self-reproach and
comorbid anxiety that characterize female MDD.
Keywords: major depressive disorder, effective connectivity, emotion regulation, dynamic causal modeling,
amygdala, prefrontal cortex
INTRODUCTION
Major depressive disorder (MDD) is one of the most prevalent of
all illnesses (Goodwin and Jamison, 2007). Elucidating neural sys-
tem abnormalities reﬂecting pathophysiologic processes in MDD
can help identify biological markers of the illness. The major-
ity of neuroimaging studies in MDD focused on examination of
activity within key neural regions supporting emotion processing
and emotion regulation, including the amygdala and orbitome-
dial prefrontal cortex (OMPFC; Siegle et al., 2002, 2007; Anand
et al., 2005; Dannlowski et al., 2007, 2009; Fales et al., 2008;
Phillips et al., 2008a). Findings from these studies indicate abnor-
mally increased amygdala activity to fear, happy, and neutral facial
expressions (Sheline et al., 2001; Abler et al., 2007; Dannlowski
et al., 2007; Fales et al., 2008), although others, no abnormali-
ties in amygdala activity to emotional stimuli in individuals with
MDD (Lawrence et al., 2004; Surguladze et al., 2005; Fu et al.,
2007; Dannlowski et al., 2008; Almeida et al., 2010b). Recent stud-
ies point to a valence speciﬁcity of amygdala hyperresponsiveness
in MDD: while depressed patients were found to show stronger
responsiveness to negative stimuli, less amygdala responsiveness
to positive stimuli has been described (Suslow et al., 2010; Vic-
tor et al., 2010). The subgenual anterior cingulate cortex (sgACC,
Brodmann Area, BA25) is one region of the OMPFC implicated in
mood regulation and processing of negative self-referential infor-
mation (Ongur et al., 2003; Phillips et al., 2008a; Price and Drevets,
2010), that has been the focus of an increasing number of neu-
roimaging studies in MDD. In MDD, volume in this region is
reduced (Drevets, 2001; Bremner et al., 2002; Wagner et al., 2008),
and resting blood ﬂow in this region is increased (Mayberg et al.,
1999; Jaracz and Rybakowski, 2002; Kito et al., 2008; Brockmann
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et al., 2009; Price and Drevets, 2010). Individuals with MDD who
respond to antidepressant treatment have greater baseline activ-
ity and metabolism in sgACC (Saxena et al., 2003; Langenecker
et al., 2007; Mulert et al., 2007; Korb et al., 2009; Keedwell et al.,
2010), and the region has more recently been used as a biological
target for deep brain stimulation for MDD (Gutman et al., 2009).
Together, these studies highlight the roles of abnormal activity in
amygdala and OMPFC in the pathophysiology of MDD.
Effective connectivity estimates are measures of the inﬂuence
that different neural regions exert over others in a given neural
system (Friston et al., 2003). These measures of function within
a neural systems are potentially more consistent over time and
sensitive than conventional neuroimaging measures of activity in
different neural regions (Schuyler et al., 2010). Dynamic causal
modeling (DCM) is an established method to estimate effective
connectivity that has been validated with concomitant functional
neuroimaging and electroencephalography (EEG), and intracere-
bral EEG in an animalmodel (David et al., 2008). The employment
of effective connectivity in neuroimaging studies of psychiatric ill-
ness therefore has the potential to identify robust biological mark-
ers of MDD. Yet, few neuroimaging studies examined effective
connectivity using DCM between neural regions of interest (ROI)
in MDD (Schlösser et al., 2008; Almeida et al., 2009c). Some stud-
ies employed functional connectivity to examine correlation over
time between regions in MDD. These studies reported decreased
functional connectivity between subcortical regions (amygdala
and ventral striatum) and prefrontal regions, including anterior
cingulate gyrus (Anand et al., 2005; Chen et al., 2008; Matthews
et al., 2008; Dannlowski et al., 2009; Heller et al., 2009; Frodl et al.,
2010), consistent with the hypothesis of decreased prefrontal cor-
tical regulation of subcortical limbic regions in MDD (Mayberg,
2003; Phillips et al., 2003; Anand et al., 2005; Price and Drevets,
2010). However, other studies showed increased connectivity
within prefrontal areas (Hamilton et al., 2011), between prefrontal
areas and thalamus (Greicius et al., 2007), and between prefrontal
areas and affective, cognitive control and defaultmode networks in
MDD (Sheline et al., 2010). Other studies showed normalization
of abnormal anterior cingulate gyral–subcortical functional con-
nectivity after pharmacological treatment in MDD (Anand et al.,
2007; Chen et al., 2008). Replication of key neuroimaging ﬁndings
is clearly essential to identify biological markers of MDD.
Using DCM, we recently demonstrated in individuals with
MDD abnormal inverse left-sided effective connectivity to positive
emotional stimuli (happy faces) between OMPFC and amygdala
(Almeida et al., 2009c). Our ﬁnding was particularly evident in
females with MDD (Cohen d ′ effect size of 0.97). There were two
main limitations to this previous study, however. First, we did
not directly compare females with males with MDD because the
majority of our sample was female. The prevalence of MDD in
females is almost double that in males (Goodwin and Jamison,
2007); yet, relationships between gender and neural system abnor-
malities in MDD remain poorly understood. Second, we included
only one sub-region of the OMPFC, ventromedial prefrontal
cortex (vmPFC, BA11).
In the present study, we therefore ﬁrst aimed to examine the
extent to which we could replicate our previous ﬁndings show-
ing abnormal inverse left-sided vmPFC–amygdala connectivity to
happy faces, especially in females with MDD. Secondly, we wished
to extend our dynamic causal model to include sgACC as a third
node to enhance our understanding of abnormal pathophysiologic
mechanisms involved in MDD. We recruited a new group of male
and female individuals with MDD, and employed a novel implicit
emotion processing and automatic attention control of emotion
paradigm. This paradigm allowed us to examine effective connec-
tivity to positive and negative emotional faces (happy, anger, fear,
and sad) in MDD and healthy individuals.
MATERIALS AND METHODS
PARTICIPANTS
Nineteen healthy individuals (12 females and 7males) and 19 indi-
viduals (12 females and 7 males) with SCID-veriﬁed (First et al.,
1995) current MDD in depressed episode (no current or past psy-
chosis) were recruited (Table 1 includes demographic and clinical
data). These groups did not differ in age [t (36)= 0.7, p = 0.5],
or estimated premorbid intellectual ability [NART (Grober and
Sliwinski, 1991), t (36)= 1.2, p = 0.2]. The Hamilton Rating Scale
for Depression (Hamilton, 1960) score in individuals with MDD
(HDRS-25-item, mean= 28.1, SD= 6.3) was signiﬁcantly greater
than healthy individuals [mean= 1.4, SD= 2.2; t (22.5)= 17.5,
p = 0.0001]. Most individuals with MDD were medicated (78.9%,
see descriptive list in Table A1 in Appendix), most had lifetime
history of comorbid anxiety disorder (63.2%), while a proportion
had lifetime history of comorbid substance disorder (26.3%).
Exclusion criteria included history of head injury (from med-
ical records and participant report), systemic medical illness,
cognitive impairment (score<24 in the Mini-Mental State Exam-
ination, premorbid IQ estimate <85 using the National Adult
Reading Test), Axis-II borderline personality disorder, and gen-
eral exclusion criteria for MRI (presence/questionable history of
metallic objects in the body, positive pregnancy test/self-reporting
of pregnancy, and proneness to panicking in enclosed spaces).
For healthy individuals, current alcohol and illicit substance abuse
(determined by SCID-I, saliva, and urine screen) were further
exclusion criteria.
The University of Pittsburgh Institutional Review Board
approved the study protocol. All participants were right-handed.
All participants were aware of the purpose of the study and gave
written informed consent after explanation of the purpose of the
research before participation in the study.
The participant population reﬂected the demographics of Pitts-
burgh and the surrounding area and/or the patient population of
the University of Pittsburgh Medical Center (UPMC). Depressed
participants were recruited from outpatient populations of the
University of Pittsburgh Medical Center (UPMC), and through
local advertising.
MEDICATION LOAD
A problem for all neuroimaging studies of psychiatric disorders is
the potential confounding effect of psychotropic medication. We
wished to examine the potential impact of psychotropic medica-
tion upon effective connectivity in MDD patients using an index
of “medication load.” This index reﬂects the number and dose of
different medications for each individual: the greater the number
and dose of the medication, the greater the medication load. This
strategy has been employed in our previous neuroimaging studies
(Hassel et al., 2008; Versace et al., 2008; Almeida et al., 2009a,c).
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Table 1 | Demographic, clinical variables, and behavior performance.
Group MDD (n=19) HI (n=19) Stat. p
Age at scan (mean/SD) 30.3 7 31.8 6.8 t (36)=0.67 0.51
Gender (Number/Percent)
Male 7 37 7 37% x2(1)=0 >0.99
Female 12 63 12 63%
Age of illness onset (mean/SD) 19.4 8.2 – – –
Illness duration (mean/SD) 11 6.1 – – –
Medication load (mean/SD) 2.6 2.2 – – –
HRSD-25 (mean/SD) 28.1 6.25 1.4 2.2 U =0 <0.001
NART (mean/SD) 114.5 9 111.2 7.3 t (36)=1.2 0.23
Level of education (mean/SD) 6.2 1.4 6.1 1.3 U =172.5 0.81
Lifetime presence of anxiety disorders (yes/no–percent yes) 12/7 63% – –
Lifetime presence of alcohol/drug abuse or dependence (yes/no–
percent yes)
5/14 26% – – –
Task performance Whole group Female Male
Stat. p Stat. p Stat. p
Color labeling accuracy for anger faces (mean/SD) 91% 9.8% 97% 3.3% U =137 0.2 U =47 0.1 U =20 0.5
Reaction time during color labeling for anger faces (ms–mean/SD) 951.4 146.9 935.9 108.7 U =172 0.8 U =68 0.8 U =18 0.4
Color labeling accuracy for fear faces (mean/SD) 94% 9.0% 96% 4.0% U =166 0.6 U =60 0.5 U =24 0.9
Reaction time during color labeling for fear faces (ms–mean/SD) 985.3 169.1 935.2 104.3 U =156 0.5 U =71 1.0 U =15 0.2
Color labeling accuracy for sad faces (mean/SD) 94% 7.5% 97% 3.8% U =151 0.4 U =47 0.1 U =24 0.9
Reaction time during color labeling for sad faces (ms–mean/SD) 956.5 168.6 950 118.5 U =174 0.9 U =62 0.6 U =22 0.7
Color labeling accuracy for happy faces (mean/SD) 92% 7.6% 95% 4.4% U =145 0.3 U =57 0.4 U =20 0.5
Reaction time during color labeling for happy faces (ms–mean/SD) 964.5 146.9 952.5 131.4 U =161 0.6 U =68 0.8 U =17 0.3
HI, healthy individuals; MDD, individuals with major depression disorder in depressed episode; SD, standard deviation; HRSD-25, 25-item Hamilton rating scale for
depression; Stat.: statistical test value; p: p value; U=Mann–Whitney U non-parametric test; ms, milliseconds; NART, national adult reading test.
To compute an index of medication load for each MDD par-
ticipant, we ﬁrst coded the dose of each antidepressant, mood-
stabilizer, antipsychotic, and anxiolytic medication as absent (0),
low (1), or high (2). For antidepressants and mood-stabilizers, we
converted eachmedication into low- or high-dose groupings using
a previously employed approach (Sackeim, 2001). Individuals on
levels 1 and 2 of these criteria were coded as low-dose, those with
levels 3 and 4 as high-dose. We added a no-dose subtype for those
not taking these medications. We converted antipsychotic doses
into chlorpromazine dose equivalents, and coded as 0, 1, or 2, for
no medication, chlorpromazine equivalents dose equal or below,
or above, the mean effective daily dose (ED50) of chlorpromazine
as deﬁned by Davis and Chen (2004). Lorazepam dose was sim-
ilarly coded as, 0, 1, or 2, with reference to the midpoint of the
Physician’s Desk Reference-recommended daily dose range. We
generated a composite measure of total medication load, reﬂect-
ing dose, and variety of different medications taken, by summing
all individual medication codes for each medication category for
each individual MDD participant.
DYNAMIC FACES TASK
Participants completed a 12.5-min emotional dynamic face pro-
cessing task during the neuroimaging procedure. Participantswere
asked to use one of three ﬁngers to press a button indicating
the color of a semi-transparent foreground color ﬂash (orange,
turquoise, or yellow) that appeared during the mid 200–650 ms
of a 1-s presentation of a dynamically changing background face
(neutral to emotional; Figure 1). These emotional faces were
considered task-irrelevant, as accurate task performance required
participants to direct attention away from these faces and toward
the color ﬂash. The task therefore essentially measures implicit
emotion processing and automatic attentional control of emotion.
Faces from the NimStim stimulus set (Tottenham et al., 2009) were
morphed in 5% increments, from neutral (0% emotion) to 100%
emotion for four emotions: happy, sad, angry, and fearful. Mor-
phed faces were made into 1 s movies progressing from 0 to 100%
emotion. In control trials, movies comprised a simple shape (dark
oval) superimposed on a light-gray oval, with similar structural
characteristics to each face stimulus,which was subsequently mor-
phed into a larger shape, approximating the movement shown by
the morphed faces. There were three blocks for each of the above
four types of emotion trial, with 12 stimuli per block, and six
control (shape) blocks, with six stimuli per block. Emotional and
control blocks were presented in a pseudorandomized order so
that no two blocks of any condition were presented sequentially.
Therefore, 36 stimuli per condition were presented in the task.
fMRI DATA ANALYSES
Neuroimaging data were collected using a 3-T Siemens Trio MRI
scanner at the Magnetic Resonance Research Center in the Uni-
versity of Pittsburgh Medical Center (MRRC). Structural 3D axial
MPRAGE images were acquired in the same session (TE: 3.29 ms,
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TR: 2200 ms, Flip angle 9˚, FOV= 256 mm× 192 mm, Slice thick-
ness: 1 mm, Matrix: 256× 256, 192 continuous slices). Blood-
oxygen-level dependent (BOLD) images were then acquired with a
gradient echo EPI sequence during 13 min covering 39 axial slices
(3.1 mm thick, TR/TE= 2000/28 ms, FOV= 205 cm× 205 cm,
matrix= 64× 64; Flip angle 90˚).
Analyses were conducted in (SPM5; http://www.ﬁl.ion.ucl.ac.
uk/spm) with slice time correction, realignment, co-registration,
normalized toMNI template, resampled to 2 mm× 2 mm× 2 mm
voxels, and smoothed with a 8-mm FWHM Gaussian kernel.
FUNCTIONAL SPECIALIZATION
A ﬁrst-level ﬁxed-effect model was constructed with four emo-
tions (anger, fear, sad, and happy) and the control condition
entered as separate regressors in the design matrix, including
movement parameters as nuisance variables and the canonical
HRF model. The four emotion versus control contrasts were then
entered into a second-level random-effects group analysis, that
was conducted on the t -contrast images generated in the previ-
ous single-subject analyses in a two (group) by four (condition)
repeated-measures analyses of variance (ANOVA). Bilateral ven-
tromedial prefrontal cortex (BA11), bilateral subgenual anterior
cingulate cortex (BA25), and bilateral amygdala ROIs included
in our analyses were deﬁned using the Wake Forest PickAtlas
Talairach Daemon Brodmann Areas (Maldjian et al., 2003). To
control for multiple statistical testing in the second-level random-
effect analysis,wemaintained a cluster-level false positive detection
rate at p< 0.05 by using a voxel threshold of p< 0.05 with a
cluster (k) extent empirically determined by Monte Carlo sim-
ulations implemented in AlphaSim, which accounted for spatial
correlations between BOLD signal changes in neighboring voxels.
FUNCTIONAL INTEGRATION: DYNAMIC CAUSAL MODELING ANALYSES
Effective connectivity (termed “connectivity” from now on) was
estimated using DCM (Friston et al., 2003; Mechelli et al., 2003)
implemented in SPM8 software, as previously employed (Almeida
et al., 2009b,c). The main goal was to replicate and extend our
previous ﬁnding regarding abnormal inverse left-sided OMPFC
(speciﬁcally the vmPFC and sgACC)–amygdala connectivity to
happy faces. We therefore included these three anatomically
deﬁned regions in our dynamic causal model. DCM uses a neu-
ronal model of distributed regional responses, and a validated
FIGURE 1 | Graphic representation of a single happy trial of our
emotional dynamic faces task. Over a 1-s duration, the face changed from
neutral (0% emotion) to a happy, sad, angry, or fearful face (100% emotion).
Participants were asked to identify the color ﬂash presented in mid dynamic
change.
biophysical model of hemodynamic signals, to model observed
fMRI responses. The ﬁtting or inversion of this model entails
optimizing both the connection strength that couple different
regions and the estimates of noise in each region. This optimiza-
tion takes place in E and M-steps respectively. Here the parameters
correspond to both the region-speciﬁc hemodynamic parameters
generating observed BOLD responses and the connectivity or cou-
pling strengths among regions (Friston et al., 2003). In this study,
we were primarily interested in endogenous connectivity among
amygdala, vmPFC, and sgACC to emotional stimuli, and between-
group differences in these connectivity measures. We therefore
focused on examination of between-group differences in con-
nectivity among the three regions to the four different emotion
conditions. We generated a separate dynamic causal model for
each emotion condition (see below). This individualized strategy
allowed us, in effect, to examine the modulatory effect of emo-
tion upon all endogenous connections in the model. We did not
therefore use bilinear or modulatory terms in our dynamic causal
model (to model changes in connectivity associated with change
in condition).
The dynamic causal model for each emotion condition com-
prised bilateral amygdala, sgACC (BA25), and vmPFC (BA11),
with reciprocal forward and backward ipsilateral connections
among these three regions (Figure 2). The structure of this
model was informed by understanding of the anatomical connec-
tions between these three regions from the large animal literature
(Ongur et al., 2003; for review: Price and Drevets, 2010), that
indicates bidirectional amygdala–vmPFC, amygdala–sgACC, and
vmPFC–sgACC connections, with each region receiving sensory
input from primary sensory processing cortices (Ongur et al.,
2003; for review: Price and Drevets, 2010). Each emotion con-
dition (happy, sad, angry, and fearful faces) was a separate input to
each node in the model. This model therefore included in total 48
connectivity estimates per participants (three pairs of bidirectional
connections in each hemisphere for each condition).
To account for individual differences, we extracted princi-
pal eigenvariates to summarize regional responses in anatomical
FIGURE 2 |The trinodal model including subgenual anterior cingulate
cortex (sgACC), ventromedial prefrontal cortex (vmPFC), and amygdala
and bidirectional connections among regions. Facial stimuli entered the
model at each node.
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templates centered on the three regions above created with the
Wake Forest University Pick Atlas (Maldjian et al., 2003). In DCM,
the units of connections are per unit time and therefore corre-
spond to rates: a strong connection means an inﬂuence that is
expressed quickly or with a large rate-constant. A positive con-
nection indicates that “high” activity in the “source” region is
associated with an increase in activity in the “target” region, while
a negative, or inverse, connection indicates that “high” activity
in the “source” region is associated with a decrease in activity in
the “target” region. The underlying model links rates of change
in the target to the level of activity in the source (Friston et al.,
2003).
BETWEEN-GROUP DIFFERENCES IN CONNECTIVITY
To assess between-group differences in connectivity we used a con-
ventional summary statistic approach, where the within-subject
estimates of coupling were passed to a second (between-subject)
level for classical inference. Individual-speciﬁc estimates of con-
nectivity were ﬁrst entered into Predictive Analytics SoftWare
(PASW, SPSS Inc.). We then used Mann–Whitney U -tests to
compare groups on connectivity measures because data were not
normally distributed.
Our primary analyses focused onour a priori connectivitymea-
sures: left sgACC–amygdala, and left vmPFC–amygdala to happy
faces (statistical threshold set at p< 0.05). We ﬁrst compared all
individuals with MDD versus healthy individuals, and then com-
pared females with MDD versus healthy females, because we had
speciﬁc a priori hypotheses about these connections in females
with MDD based on our previous study (Almeida et al., 2009c).
We also compared males with MDD relative to healthy males,
although the smaller number of males made this comparison
preliminary only.
In parallel analyses,we performed between-group comparisons
on the remaining connectivity measures to all four emotion con-
ditions (happy anger, fear, and sad). Here, we used the sequential
goodness of ﬁt (SGoF) metatest to correct for multiple test of
between-group differences in the remaining 46 connectivity mea-
sures (6 pairs× 2 hemispheres× 4 emotional conditions, minus
the above two a priori measures). The SGoF is an especially good
method to correct for multiple tests in data sets where the sam-
ple size is not large, when the hypothesis to be tested may be
weakly to moderately deviated from the null hypothesis, when
there may be widespread effects through the family of tests, and
when the number of tests is large (Carvajal-Rodriguez et al., 2009).
The method is based on a comparison of the expected likely false
positive error rate over all tests (computed from the per test sig-
niﬁcance level and the total number of tests performed), and
the observed number of tests that meet the per test signiﬁcance
level. Contrary to other methods, the SGoF increases its statis-
tical power with the number of tests, resolving in this way the
trade-off between false positive ﬁnding (type I error) and statistical
power (Carvajal-Rodriguez et al., 2009), and can show a statistical
power up to two orders of magnitude higher than the Bonfer-
roni method without increasing the false discovery rate (FDR).
The SGoF is therefore an appropriate analytic strategy for mul-
titest correction when working with high-dimensional biological
data.
EXPLORATORY ANALYSES
In exploratory analyses, we compared healthy males with females,
and males with females with MDD on connectivity measures
that showed signiﬁcant between-group differences. Connectivity
measures showing signiﬁcant abnormalities were also explored
for possible relationships, using Spearman rank correlation tests
and Mann–Whitney U -tests as appropriate, with: age, age of ill-
ness onset, illness duration, depression severity (measured using
the HRSD-25), medication load (see Appendix), taking versus
not taking individual psychotropic medication classes, and life-
time history of comorbid anxiety and/or substance disorder.
Here, in individuals with MDD, we used a statistical thresh-
old of p = 0.05/10= 0.005, to control for the 10 separate tests
for each connectivity measure. For healthy individuals, relation-
ships between connectivity measures and age and subthreshold
depression symptom severity using the HRSD-25 were examined
using Spearman rank correlation tests and a statistical thresh-
old of p = 0.05/2= 0.025, to control for the two tests for each
connectivity measure.
RESULTS
TASK PERFORMANCE
Task performance accuracy was high: 91% face color labeling
accuracy for individuals with MDD, and 94% face color label-
ing accuracy for healthy individuals. There were no signiﬁcant
between-group differences in all individuals, females, or males in
accuracy or reaction time, for any emotion condition (Table 1).
FUNCTIONAL SPECIALIZATION ON vmPFC, sgACC, AND AMYGDALA
ROIs
We found no signiﬁcant main effect of group or interaction; how-
ever, we found a signiﬁcant positive effect of condition in all
ROI bilaterally. Thus, revealing that the individuals recruited these
regions to perform the task (Table 2).
DYNAMIC CAUSAL MODELING
Primary analyses: between-group differences in left
vmPFC–amygdala and sgACC–amygdala connectivity to happy faces
Comparison of all individuals with MDD and healthy individuals
did not reveal any signiﬁcant differences in left vmPFC–amygdala
or sgACC–amygdala connectivity to happy faces. Comparison
of females with MDD relative to healthy females replicated our
previous ﬁnding of signiﬁcantly greater inverse left-sided vmPFC–
amygdala connectivity to happy faces, and extended this to also
show signiﬁcantly greater inverse left-sided sgACC–amygdala con-
nectivity in femaleswithMDDrelative to healthy females (p = 0.04
and p = 0.02, respectively). Males with MDD did not differ signiﬁ-
cantly from healthy males in either of these connectivity measures
(Table 3; Figure 3).
Parallel analysis: remaining connectivity measures
For all individuals with MDD versus all healthy individuals, ﬁve
pairwise between-group comparisons met the per test signiﬁ-
cance threshold of p = 0.05 (Table 4). One of these compar-
isons survived SGoF correction: all individuals with MDD relative
to healthy individuals showed signiﬁcantly greater positive left-
sided sgACC–amygdala connectivity (p = 0.003) to fearful faces
(Table 3; Figure 4).
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Table 2 | Effective connectivity estimates in a priori and parallel analysis to happy, angry, sad, and fearful faces.
A priori analysis MDD (n=19) HI (n=19) Whole group Females only Males only
Mean SD Mean SD MW p MW p MW p
LEFTTOP-DOWN CONNECTIVITYTO HAPPY FACES
vmPFC–Amy −0.0004 0.003 0.0012 0.005 130 0.14 37 0.04# 22 0.75
sgACC–Amy −0.0006 0.002 0.0008 0.003 118 0.07 32 0.02# 22 0.75
Parallel analysis
HAPPY FACES
vmPFC–sgACC left 0.0002 0.001 0.0008 0.003 139 0.23 26 0.008** 14 0.18
vmPFC–sgACC right −0.0003 0.002 −0.0001 0.004 135 0.18 38 0.05* 21 0.65
FEARFUL FACES
sgACC–amygdala left 0.0024 0.003 −0.0002 0.002 77 0.003** 26 0.008** 15 0.22
vmPFC–sgACC right 0.0006 0.002 −0.0003 0.003 157 0.49 38 0.05* 10 0.06
vmPFC–sgACC left 0.0004 0.002 −0.0011 0.005 143 0.27 32 0.02* 14 0.18
vmPFC–amygdala left 0.0003 0.002 −0.0011 0.007 147 0.33 34 0.03* 13 0.14
ANGRY FACES
Amygdala–vmPFC left 0.0003 0.003 −0.0018 0.004 108 0.03* 42 0.08 15 0.22
SAD FACES
Amygdala–sgACC right −0.0003 0.002 0.0016 0.003 106 0.03* 45 0.12 12 0.11
sgACC–amygdala right −0.0007 0.003 0.0008 0.002 122 0.09 69 0.86 8 0.04*
vmPFC–sgACC right −0.0007 0.002 0.0013 0.005 114 0.05* 60 0.49 4 0.009*
sgACC–vmPFC right −0.0008 0.003 0.0020 0.004 103 0.02* 42 0.08 12 0.11
sgACC–vmPFC left 0.0003 0.002 0.0025 0.003 122 0.09 64 0.64 8 0.04*
HI, healthy individuals; MDD, individuals with major depression disorder in depressed episode; vmPFC, ventromedial prefrontal cortex; sgACC, subgenual prefrontal
cortex; ∗p value survives alpha<0.05 but does not survive SGoF correction for multiple tests; ∗∗p value survives SGoF correction for multiple tests; #p value survive
a priori alpha threshold of p<0.05; SD, standard deviation; MW, Mann–Whitney U non-parametric test; SGoF, sequential goodness of ﬁt.
Table 3 | Amygdala, vmPFC, and sgACC activity during the dynamic faces task.
Region Side Mini coordinators K T Z P
X Y Z
POSITIVE EFFECT OF CONDITION
vmPFC (BA11) R 4 52 −14 28 2.61 2.57 0.05**
L −4 54 −12 11 2.23 2.21 0.013*
sgACC (BA25) R 2 8 −14 7 2.18 2.14 0.016*
L −2 6 −12 4 1.74 1.73 0.041*
Amygdala R 20 −4 −16 114 3.72 3.63 0.024**
L −20 −6 −16 113 2.89 2.84 0.049**
vmPFC, ventromedial prefrontal cortex; sgACC, subgenual anterior cingulate cortex; R, right; L, left; BA, Brodmann area; coordinates correspond to the stereotaxic
array of Montreal Neurologic Institute; k: cluster size; ∗alphasim correction; ∗∗false discovery rate correction.
For females with MDD versus healthy females, six pairwise
between-group comparisons met the per test signiﬁcance thresh-
old of p = 0.05 (Table 4). Two of these comparisons survived
SGoF correction. 1. to happy faces: signiﬁcantly reduced posi-
tive left-sided vmPFC–sgACC connectivity (p = 0.008) in females
with MDD relative to healthy females. 2. to fearful faces: signif-
icantly greater positive left-sided sgACC–amygdala connectivity
(p = 0.008), where females with MDD showed a positive connec-
tivity, healthy females showed an inverse connectivity (Table 3;
Figure 4).
For males with MDD relative to healthy males, three pairwise
between-group comparisons met the threshold of p = 0.05, but
none survived SGoF correction (Tables 3 and 4).
Within-group gender comparison
In healthy individuals, the left-sided vmPFC–sgACC connectivity
to happy faces that survived the SGoF correction for between-
group differences in connectivity in female participants showed
a signiﬁcant effect of gender. Here, healthy females had posi-
tive, and healthy males, inverse connectivity between these regions
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FIGURE 3 | Primary a priori analysis.Top: inverse left-sided
vmPFC–amygdala connectivity to happy faces in females with MDD.
Bottom: inverse left-sided sgACC–amygdala connectivity to happy faces in
females with MDD.
(p = 0.022). In individuals with MDD, there were no signiﬁcant
effects of gender on any of the connectivity measures that survived
the SGoF correction for examinationof between-groupdifferences
in connectivity.
Exploratory relationships between abnormal connectivity and age,
task performance, and illness history
In individuals with MDD, there were no signiﬁcant relation-
ships between any clinical, demographic, or task performance
measure and connectivity measures showing between-group dif-
ferences in connectivity using the Bonferroni-corrected threshold
of p ≤ 0.005 (Table 5). In healthy individuals, however, there was
a signiﬁcant negative correlation between sub-syndromal depres-
sive symptoms, and left sgACC–amygdala connectivity to happy
faces (p = 0.01). Here, greater sub-syndromal depressive symptom
severity was associated with reduced left-sided sgACC–amygdala
connectivity to happy faces (Table 6).
DISCUSSION
The goal of the present study was to identify neuroimaging mea-
sures of recurrent MDD in females by examining the extent to
which we could replicate in an independent sample, of females
with MDD, and extend to a trinodal model, our previous ﬁnding
of abnormal inverse left-sided OMPFC–amygdala connectivity to
positive emotional stimuli (happy faces). In a priori hypothesis
testing, we replicated our previous ﬁnding of abnormal inverse
left-sided vmPFC–amygdala connectivity, and also showed abnor-
mal inverse left-sided sgACC–amygdala connectivity, to happy
faces in females (but not males) with MDD. Parallel analyses
across all other remaining connectivity measures in our trinodal
dynamic causal model revealed abnormally reduced positive left-
sided vmPFC–sgACC connectivity, to happy faces, and abnormal
positive left-sided sgACC–amygdala connectivity to fearful faces
in females with MDD. Our present and previous ﬁndings high-
light the fact that gender is an important factor to be considered
in neuroimaging studies of MDD, and that abnormal left-sided
OMPFC–amygdala connectivity during processing of both happy
and fearful stimuli may be speciﬁc to female MDD.
Females experience depression at a rate twice that of males
(Kendler et al., 2002; McGrath et al., 2009). Females are also more
likely than males to have atypical depression, characterized by
transient mood reactivity to actual or potential positive events,
increase in appetite, hypersomnia, interpersonal rejection sensi-
tivity and/or comorbid anxiety (APA, 2000), and are more likely
to describe interpersonal stress and excessive self-reproach (Ham-
men, 2003; Smith et al., 2008). Interpretation of the abnormal
patterns of connectivity between vmPFC, sgACC, and amygdala
to happy and fearful faces in females with MDD in the context of
these clinical features of female MDD can be guided by previous
studies that elucidated the roles of the vmPFC and sgACC in emo-
tion regulation. Both vmPFC and sgACC are part of the medial
network within OMPFC implicated in emotion and visceromotor
regulation (Ongur et al., 2003; Price and Drevets, 2010) and have
strong reciprocal connections with the amygdala (Ongur et al.,
2003; Price and Drevets, 2010). Human neuroimaging studies
implicate both bilateral sgACC (Williams et al., 2006) and vmPFC
(Van Veen and Carter, 2002; Luks et al., 2007) in fear extinction,
an example of automatic behavioral control of emotion (Phillips
et al., 2008b). The left vmPFC is also implicated in aversive con-
ditioning (Gottfried and Dolan, 2004), while left/bilateral sgACC
are implicated in the generation of sad mood (Mayberg, 1999),
depression (Mayberg, 2005), and elevated monitoring of internal
states in individuals with attachment avoidant personality styles
(Gillath et al., 2005). The pattern of abnormal inverse or reduced
positive connectivity between sgACC, vmPFC, and amygdala to
happy faces may therefore reﬂect abnormal inhibition, or reduced
functional integration, in this circuitry during positive emotion
processing, that may lead to abnormally increased regulation of
emotional response to, and reduced representation of the positive
emotional value of, positive emotional stimuli in female MDD.
This in turn may be associated with only transient positive mood
reactivity to positive events and excessive self-reproach observed
in female MDD. By contrast, the abnormally elevated left-sided
positive sgACC–amygdala connectivity to fearful faces in females
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Table 4 | Effective connectivity estimates to happy, fearful, sad, and angry faces.
MDD (n=19) HI (n=19) Whole group Females only males only
Mean SD Mean SD MW p MW p MW p
HAPPY FACES
Amygdala–sgACC left 0.0010 0.002 0.0000 0.003 153 0.42 66 0.73 19 0.48
Amygdala–sgACC right 0.0013 0.003 −0.0002 0.003 141 0.25 58 0.42 19 0.48
Amygdala–vmPFC left 0.0021 0.006 −0.0003 0.003 148 0.34 51 0.23 22 0.75
Amygdala–vmPFC right 0.0015 0.005 0.0001 0.003 163 0.61 55 0.33 21 0.65
sgACC–Amy left −0.0006 0.002 0.0008 0.003 118 0.07 32 0.02* 22 0.75
sgACC–amygdala right 0.0003 0.002 −0.0004 0.003 172 0.80 60 0.49 23 0.85
sgACC–vmPFC left 0.0001 0.002 0.0020 0.005 147 0.33 51 0.23 22 0.75
sgACC–vmPFC right 0.0000 0.002 0.0010 0.003 144 0.29 50 0.20 24 0.95
vmPFC–Amy left −0.0004 0.003 0.0012 0.005 130 0.14 37 0.04# 22 0.75
vmPFC–amygdala right −0.0005 0.003 −0.0004 0.005 158 0.51 66 0.73 19 0.48
vmPFC–sgACC left 0.0002 0.001 0.0008 0.003 139 0.23 26 0.008** 14 0.18
vmPFC–sgACC right −0.0003 0.002 −0.0001 0.004 135 0.18 38 0.05* 21 0.65
ANGRY FACES
Amygdala–sgACC left 0.0003 0.002 −0.0005 0.003 120 0.08 46 0.13 23 0.85
Amygdala–sgACC right −0.0002 0.003 0.0000 0.004 148 0.34 39 0.06 14 0.18
Amygdala–vmPFC left 0.0003 0.003 −0.0018 0.004 108 0.03* 42 0.08 15 0.22
Amygdala–vmPFC right −0.0001 0.002 −0.0002 0.004 140 0.24 65 0.69 12 0.11
sgACC–amygdala left −0.0003 0.003 0.0012 0.005 158 0.51 51 0.23 22 0.75
sgACC–amygdala right −0.0011 0.006 −0.0001 0.004 167 0.69 65 0.69 16 0.28
sgACC–vmPFC left −0.0006 0.003 −0.0013 0.007 175 0.87 71 0.95 24 0.95
sgACC–vmPFC right −0.0003 0.002 −0.0010 0.006 158 0.51 48 0.17 18 0.41
vmPFC–amygdala left −0.0005 0.002 0.0009 0.005 162 0.59 71 0.95 17 0.34
vmPFC–amygdala right −0.0015 0.004 −0.0001 0.005 180 0.99 55 0.33 15 0.22
vmPFC–sgACC left 0.0011 0.003 0.0011 0.005 167 0.69 67 0.77 18 0.41
vmPFC–sgACC right 0.0008 0.003 0.0001 0.004 158 0.51 55 0.33 23 0.85
FEARFUL FACES
Amygdala–sgACC left 0.0002 0.004 0.0007 0.004 167 0.69 69 0.86 18 0.41
Amygdala–sgACC right −0.0001 0.003 −0.0003 0.004 171 0.78 71 0.95 19 0.48
Amygdala–vmPFC left 0.0002 0.003 0.0007 0.006 159 0.53 62 0.56 21 0.65
Amygdala–vmPFC right −0.0003 0.004 −0.0003 0.006 180 0.99 64 0.64 18 0.41
sgACC–amygdala left 0.0024 0.003 −0.0002 0.002 77 0.003** 26 0.008** 15 0.22
sgACC–amygdala right 0.0004 0.003 −0.0003 0.003 152 0.41 44 0.11 20 0.57
sgACC–vmPFC left 0.0002 0.005 −0.0011 0.004 140 0.24 56 0.36 19 0.48
sgACC–vmPFC right 0.0004 0.005 −0.0007 0.004 158 0.51 63 0.60 22 0.75
vmPFC–amygdala left 0.0003 0.002 −0.0011 0.007 147 0.33 34 0.03* 13 0.14
vmPFC–amygdala right 0.0003 0.002 −0.0012 0.005 134 0.17 40 0.06 21 0.65
vmPFC–sgACC left 0.0004 0.002 −0.0011 0.005 143 0.27 32 0.02* 14 0.18
vmPFC–sgACC right 0.0006 0.002 −0.0003 0.003 157 0.49 38 0.05* 10 0.06
SAD FACES
Amygdala–sgACC left −0.0008 0.004 0.0012 0.004 158 0.51 66 0.73 12 0.11
Amygdala–sgACC right −0.0003 0.002 0.0016 0.003 106 0.03* 45 0.12 12 0.11
Amygdala–vmPFC left 0.0006 0.003 0.0018 0.004 179 0.97 66 0.73 22 0.75
Amygdala–vmPFC right 0.0006 0.003 0.0013 0.003 167 0.69 66 0.73 21 0.65
sgACC–amygdala left −0.0008 0.002 0.0013 0.003 129 0.13 57 0.39 13 0.14
sgACC–amygdala right −0.0007 0.003 0.0008 0.002 122 0.09 69 0.86 8 0.04*
sgACC–vmPFC left 0.0003 0.002 0.0025 0.003 122 0.09 64 0.64 8 0.04*
sgACC–vmPFC right −0.0008 0.003 0.0020 0.004 103 0.02* 42 0.08 12 0.11
vmPFC–amygdala left −0.0002 0.004 0.0010 0.004 139 0.23 58 0.42 16 0.28
vmPFC–amygdala right −0.0005 0.003 0.0013 0.005 144 0.29 60 0.49 17 0.34
(Continued)
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Table 4 | Continued
MDD (n=19) HI (n=19) Whole group Females only males only
Mean SD Mean SD MW p MW p MW p
vmPFC–sgACC left −0.0007 0.002 0.0012 0.006 129 0.13 62 0.56 13 0.14
vmPFC–sgACC right −0.0007 0.002 0.0013 0.005 114 0.05* 60 0.49 4 0.009*
HI, healthy individuals; MDD, individuals with major depression disorder in depressed episode; vmPFC, ventromedial prefrontal cortex; sgACC, subgenual prefrontal
cortex; ∗p value survives alpha<0.05 but does not survive SGoF correction for multiple tests; ∗∗p value survives SGoF correction for multiple tests; #p value survive
a priori alpha threshold of p<0.05; SD, standard deviation; MW, Mann–Whitney U non-parametric test; SGoF, sequential goodness of ﬁt.
with MDD may represent a neural mechanism for the abnormally
increased representation of threat depicted by fearful faces, which
in turn may be related to the comorbid anxiety and interpersonal
stress associated with female MDD.
Interpretation of the abnormal patterns of sgACC–amygdala
connectivity to happy and fearful faces in females with MDD can
also be guided by previous neuroimaging studies that focused on
the sgACC in MDD. Previous studies provide increasing evidence
that differential patterns of sgACC activity to negative versus pos-
itive emotional stimuli may moderate and mediate response to
different antidepressant treatments in MDD. Previous ﬁndings
indicate, for example, that greater levels of activity in individuals
with MDD in the sgACC to negative emotional stimuli may pre-
dict subsequent successful response to antidepressant treatment
(Saxena et al., 2003; Langenecker et al., 2007; Mulert et al., 2007;
Korb et al., 2009; Keedwell et al., 2010). Other ﬁndings show that
successful response to antidepressant treatments is paralleled by
decreased activity in sgACC to negative emotional stimuli (Anand
et al., 2007; Fu et al., 2007; Chen et al., 2008; Keedwell et al., 2010),
but by greater activity in this region to positive emotional stimuli
(Fu et al., 2007;Keedwell et al., 2010). These ﬁndings therefore sug-
gest that differential patterns of sgACC activity to negative versus
positive emotional stimuli may reﬂect pathophysiologic processes
of MDD. Little is yet known, however, regarding the extent to
which differential patterns of abnormal connectivity between the
sgACC and amygdala to positive versus negative emotional stim-
ulimay reﬂect different pathophysiologic processes associatedwith
female versusmaleMDD,ormaymoderate andmediate treatment
response in the illness in females and males.
No previous neuroimaging studies directly compared females
and males with MDD during emotion processing tasks. Previous
studies that focused only on females with MDD indicate abnormal
OMPFC and amygdala activity to emotional stimuli in females
with MDD versus healthy females. For example, these previous
studies showed abnormally increased bilateral amygdala activity to
negative emotional stimuli, and abnormally increased left sgACC
activity to positive emotional stimuli (Abler et al., 2007), although
no difference in amygdala or OMPFC activity during a cogni-
tive control of emotion task between females with high severity
depression symptoms compared to females with low depression
symptoms (Beevers et al., 2010). Females with MDD recovered
from depression were reported to show greater right amygdala
and reduced left ACC activity to parental criticism stimuli, and
reduced right ACC activity to parental praise and neutral stimuli
compared to healthy females (Hooley et al., 2009). Previous studies
FIGURE 4 | Parallel analysis.Top: greater positive left-sided
sgACC–amygdala connectivity to fearful faces in females with MDD.
Bottom: reduced positive left-sided vmPFC–sgACC connectivity to happy
faces in females with MDD.
also indicate greater activity in left ACC and right lateral prefrontal
cortex to positive emotional stimuli in females with MDD ver-
sus healthy females (Mitterschiffthaler et al., 2003). Another study
showed greater left ACC and left dorsolateral prefrontal cortical
activity (Wagner et al., 2006) and greater effective connectivity
between left dorsal and rostral ACC during performance of the
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Table 5 | Relation between effective connectivity, clinical, demographic, and experiment performance variables in individuals with MDD.
Happy faces Fearful faces
Left-sided
sgACC–Amy EC
Left-sided
vmPFC–Amy EC
Left-sided
vmPFC–sgACC EC
Left-sided
sgACC–Amy EC
Females only;
MDD (n=12)
Females only;
MDD (n=12)
Females only;
MDD (n=12)
Whole group;
MDD (n=19)
Females only;
MDD (n=12)
Rho pValue Rho pValue Rho pValue Rho pValue Rho pValue
Age at scan 0.08 0.80 0.24 0.46 0.13 0.68 −0.12 0.63 0.13 0.70
Age of illness onset −0.18 0.58 0.35 0.26 0.41 0.18 0.00 0.99 −0.05 0.87
Illness duration 0.15 0.65 −0.24 0.46 −0.37 0.24 0.06 0.81 0.17 0.59
Medication load 0.23 0.47 0.06 0.86 −0.21 0.51 −0.49 0.03* −0.22 0.50
HRSD-25 0.30 0.34 0.13 0.69 −0.04 0.91 −0.17 0.48 −0.36 0.24
Accuracy emotional face −0.23 0.47 0.13 0.69 −0.25 0.43 −0.24 0.32 −0.09 0.79
Reaction time emotional face 0.14 0.66 −0.04 0.90 0.57 0.06 −0.08 0.75 0.13 0.68
MW pValue MW pValue MW pValue MW pValue MW pValue
Mood stabilizators (on/off) 0 0.11 1 0.19 4 0.66 12 0.18 2 0.31
Anti psychotic medications (on/off) 6 0.39 4 0.20 10 1.00 19 0.58 5 0.28
Anti depressants (on/off) 12 0.78 10 0.52 8 0.30 13 0.09 9 0.41
Benzodiazepines (on/off) 4 0.08 12 0.78 12 0.78 28 0.24 12 0.78
Lifetime presence of alcohol/drugs
Abuse or dependence (yes/no)
13 0.93 11 0.64 12 0.78 13 0.04* 6 0.17
Lifetime presence of anxiety disor-
der (yes/no)
16 0.81 8 0.12 13 0.46 16 0.03* 5 0.04*
MDD, individuals with major depression disorder in depressed episode; MW, Mann–Whitney U; Rho: Spearman rank correlation; HRSD-25: 25-item Hamilton rating
scale for depression; vmPFC, ventromedial prefrontal cortex; sgACC, subgenual prefrontal cortex; ∗p does not survive multiple correction; EC, effective connectivity.
Table 6 | Relation between effective connectivity, clinical, demographic, and experiment performance variables in HI.
Happy faces Fearful faces
Left-sided
sgACC–Amy EC
Left-sided
vmPFC–Amy EC
Left-sided
vmPFC–sgACC EC
Left-sided
sgACC–Amy EC
Females only Females only Females only Whole group Females only
HI (n=12) HI (n=12) HI (n=12) HI (n=19) HI (n=12)
Rho pValue Rho pValue Rho pValue Rho pValue Rho pValue
Age at scan −0.59 0.04* −0.40 0.20 −0.43 0.16 −0.35 0.15 −0.59 0.04*
HRSD-25 −0.69 0.01** −0.48 0.11 −0.26 0.42 −0.06 0.82 −0.32 0.32
Accuracy emotional face −0.19 0.55 −0.27 0.40 0.00 1.00 −0.45 0.05* −0.34 0.28
Reaction time Emotional face −0.50 0.10 −0.37 0.24 −0.31 0.32 0.24 0.33 0.31 0.33
HI, healthy individuals; Rho, Spearman rank correlation; HRSD-25, 25-item Hamilton rating scale for depression; vmPFC, ventromedial prefrontal cortex; sgACC,
subgenual prefrontal cortex; ∗p does not survive multiple correction; ∗∗p value survives multiple correction; EC, effective connectivity.
incongruent condition of the Stroop task in females with MDD
relative to healthy females (Schlösser et al., 2008). Together with
our present ﬁndings, these ﬁndings therefore suggest abnormal
functional integrationbetween,predominantly, left-sidedOMPFC
and bilateral amygdala to positive and negative emotional stimuli,
and also during attentional tasks, in females with MDD. Further
studies are clearly needed to elucidate pathophysiologic processes
that may differ between male and female MDD.
A popular theory emphasizes the role of the left hemi-
sphere in processing approach-related emotional stimuli (David-
son et al., 1990; Sutton and Davidson, 1997). Cognitive neuro-
science accounts of face processing, however, highlight the role
of the left hemisphere as critical in “detail-oriented” processing,
whereas the right hemisphere may support “gestalt” processing
(Sergent and Bindra, 1981; Rossion et al., 2000). Our ﬁndings
therefore suggest that the left-lateralized pattern of abnormal
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connectivity in females with MDD may reﬂect not only abnor-
mal processing of approach-related emotional stimuli, but also the
employment of detail-oriented left-hemisphere-centered strate-
gies during implicit processing of the emotional faces, and auto-
matic regulation of response to these stimuli, to a greater extent
than other groups. This should be the focus of future studies.
Examination of gender differences in connectivity measures
thatwere abnormal in individualswithMDDrevealed signiﬁcantly
greater inverse left-sided vmPFC–sgACC connectivity to happy
faces in healthy males relative to healthy females, such that healthy
males showed a pattern of connectivity between these regions that
was more similar to that shown by females with MDD than that
shown by healthy females. These ﬁndings suggest that one patho-
physiologic process in female MDD is to render the functional
integrity within left-sided vmPFC–sgACC circuitry during posi-
tive emotion processing similar to that shown by healthy males,
but this requires further study. Interestingly, in healthy individ-
uals, more severe sub-syndromal depression was associated with
signiﬁcantly reduced left-sided sgACC–amygdala connectivity to
happy faces, a connectivity pattern that resembled females with
MDD.
While a limitation of our study was the small number of males
with MDD, our main focus was to examine OMPFC–amygdala
connectivity to positive and negative emotional stimuli in females
with MDD. Another limitation was the recruitment of medicated
individuals with MDD, although our ﬁndings indicate normal-
izing rather than confounding effects of such medication upon
one of our connectivity measures, providing a valuable insight
into putative neural mechanisms that may mediate antidepressant
treatment response in MDD. Further replications of our current
and previous ﬁndings are clearly needed in future studies. Future
studies can determinewhether the observed group differences rep-
resent state or trait markers of depression by including individuals
who have recovered from depression in analyses. Future studies
can also aim to examine the extent to which adolescents and adults
at potential future risk of mood disorders show these patterns
of abnormal connectivity between vmPFC and amygdala dur-
ing emotion processing paradigms. Furthermore, given promising
ﬁndings from activation studies in MDD, showing that baseline
activity in frontocingulate areas may predict future treatment
response in MDD (Almeida et al., 2010a; Pizzagalli, 2011), future
studies can also aim to examine the extent to which measures
of abnormal connectivity may also predict treatment response in
MDD.
In conclusion, we replicated our previous ﬁnding of abnor-
mal inverse left-sided OMPFC–amygdala connectivity to positive
emotional stimuli in an independent group of females with MDD
using a novel implicit emotion processing paradigm. Our present
ﬁndings show a more extensive pattern of abnormal left-sided
connectivity among sgACC, vmPFC, and amygdala to happy and
fearful faces in females, but not males, with MDD. The differen-
tial pattern of abnormal left-sided OMPFC–amygdala connectiv-
ity to happy and fearful faces may therefore represent a neural
mechanism for female MDD, which is characterized by comor-
bid anxiety and high levels of interpersonal stress. Our ﬁndings
highlight the utility of effective connectivity studies in identifying
gender-speciﬁc markers of MDD that may help identify potential
biological targets for novel,personalized treatments for individuals
with MDD.
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APPENDIX
Table A1 | Descriptive list of medication for each individual with major depressive disorder.
Subject Drug name
1 Bupropion
2 N/A
3 Bupropion
4 Fluvoxamine Clonazepam Risperidona
5 Fluoxetine Clonazepam
6 Fluoxetine
7 Venlafaxine Bupropion
8 N/A
9 Lithium Trazodone Clonazepam
10 Paroxetine Temazepam Chlorpromazine Gabapentin Lorazepam
11 Venlafaxine Trazodone
12 Lorazepam Desipramine Lamotrigine Mirtazapine
13 N/A
14 Duloxetine
15 Duloxetine
16 Citalopram Bupropion
17 Alprazolam Citalopram
18 N/A
19 Aripiprazole Zolpidem Venlafaxine
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